Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20131214015782N7Phase 3Not yet recruiting
Phase 3, randomised, double-blind trial of nabumetone and ibuprofen in postoperative pain and irreversible pulpitis (4 arms), sponsored by Islamic Azad University, Tehran Dental Branch. Primary endpoint: Pain severity. Planned start Apr 2639; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20131214015782N7.